US2020253546A1PendingUtilityA1

Device, method and system for implementing a physical area network for cancer immunotherapy

Individually held — no corporate assignee on recordPriority: Dec 12, 2018Filed: Apr 29, 2020Published: Aug 13, 2020
Est. expiryDec 12, 2038(~12.4 yrs left)· nominal 20-yr term from priority
H04B 13/005A61B 5/0024A61B 5/6861A63F 13/212A61B 5/065H04B 10/90A63F 13/23A61B 5/4839A61B 5/07A61B 5/6833A61B 2562/0285A61K 41/00
69
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A physical area network described herein enables significantly improved health monitoring and treatment by utilizing internal (in-body) mechanisms and information and external mechanisms and information.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . An apparatus comprising:
 a memory configured for storing an application, the application configured for:
 communicating, using an apparatus communication device, with a set of nano-nodes, wherein at least one first nano-node in the set of nano-nodes includes a nano-node communication device to communicate with the apparatus communication device, wherein a surface of at least one second nano-node in the set of nano-nodes is encapsulated with one or more plasma membrane-associated components, and wherein the one or more plasma membrane-associated components are derived from a cancer cell, further wherein the at least one second nano-node in the set of nano-nodes encapsulated with the one or more plasma membrane-associated components is configured for activating an immune response against the cancer cell in a user, thereby treating the cancer; and 
   a processor configured for processing the application.   
     
     
         2 . The apparatus of  claim 1  wherein the apparatus comprises a nano-micro interface. 
     
     
         3 . The apparatus of  claim 1  wherein the application is further configured for determining a distance from the apparatus communication device to the at least one first nano-node in the set of nano-nodes. 
     
     
         4 . The apparatus of  claim 3  wherein the distance is based on a number of hops from the apparatus communication device to the at least one first nano-node in the set of nano-nodes. 
     
     
         5 . The apparatus of  claim 1  wherein the apparatus communication device is configured for sending a communication to the at least one first nano-node using a fewest number of hops. 
     
     
         6 . The apparatus of  claim 1  wherein the apparatus communication device is configured for receiving a nano-node identifier from the at least one first nano-node. 
     
     
         7 . The apparatus of  claim 1  wherein the apparatus communication device comprises a nano-communication transceiver to communicate with the at least one first nano-node in the set of nano-nodes and translate nano-communications to micro-communications. 
     
     
         8 . The apparatus of  claim 1  further comprising a hacking prevention implementation. 
     
     
         9 . The apparatus of  claim 8  wherein the hacking prevention implementation comprises a shielding component. 
     
     
         10 . The apparatus of  claim 1  wherein the application is further configured for timestamping a communication with the at least one first nano-node. 
     
     
         11 . The apparatus of  claim 1  wherein the apparatus communication device is configured for utilizing a plurality of channels for communication. 
     
     
         12 . The apparatus of  claim 1  wherein the application is further configured for receiving a plurality of portions of data from the at least one first nano-node in the set of nano-nodes and combining the portions of data to generate a complete data. 
     
     
         13 . The apparatus of  claim 1  wherein the application is further configured for accessing a mapping of locations of the set of nano-nodes. 
     
     
         14 . The apparatus of  claim 1  wherein the apparatus communication device comprises a graphene-based antenna. 
     
     
         15 . The apparatus of  claim 1  wherein the apparatus communication device is configured for communicating at a plurality of frequencies. 
     
     
         16 . The apparatus of  claim 1  wherein the application is further configured for encrypting a communication to the at least one first nano-node in the set of nano-nodes. 
     
     
         17 . The apparatus of  claim 16  wherein the application is further configured for utilizing DNA-based encryption for encrypting the communication to the at least one first nano-node in the set of nano-nodes. 
     
     
         18 . The apparatus of  claim 1  wherein the application is configured for determining multiple paths to the at least one first nano-node in the set of nano-nodes and determining a shortest path of the multiple paths to the least one first nano-node in the set of nano-nodes. 
     
     
         19 . The apparatus of  claim 1  further comprising a second apparatus communication device configured for communicating information received from the at least one first nano-node to an external device. 
     
     
         20 . A system comprising:
 a first set of nano-nodes; and   a second set of nano-nodes, wherein at least one nano-node of the first set of nano-nodes includes a communication device to communicate with at least one nano-node of the second set of nano-nodes, wherein the communication device utilizes in vivo, terahertz communication and accounts for a transmission medium when sending a communication, wherein a surface of at least one nano-node of the first set of nano-nodes or the second set of nano-nodes is encapsulated with one or more plasma membrane-associated components, and wherein the one or more plasma membrane-associated components are derived from a cancer cell, wherein the at least one nano-node of the first set of nano-nodes or second set of nano-nodes encapsulated with one or more plasma membrane-associated components is for activating an immune response against the cancer cell in a user, thereby treating the cancer.

Join the waitlist — get patent alerts

Track US2020253546A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.